Roles of IL-6-gp130 Signaling in Vascular Inflammation. - sprookjes - yvandenbroek - TriplyDB

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

http://www.wikidata.org/entity/Q37429079

about

Transcriptome and Molecular Endocrinology Aspects of Epicardial Adipose Tissue in Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Observational Studies Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date Pulmonary instillation of MWCNT increases lung permeability, decreases gp130 expression in the lungs, and initiates cardiovascular IL-6 transsignaling The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis Gp130-dependent release of acute phase proteins is linked to the activation of innate immune signaling pathways.The future of EPAC-targeted therapies: agonism versus antagonism Expanding role of cyclin dependent kinases in cytokine inducible gene expression.Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.Heart regeneration, stem cells, and cytokines.Calyculin A reveals serine/threonine phosphatase protein phosphatase 1 as a regulatory nodal point in canonical signal transducer and activator of transcription 3 signaling of human microvascular endothelial cells.Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar.The STAT3 NH2-terminal domain stabilizes enhanceosome assembly by interacting with the p300 bromodomain.Flavanoids induce expression of the suppressor of cytokine signalling 3 (SOCS3) gene and suppress IL-6-activated signal transducer and activator of transcription 3 (STAT3) activation in vascular endothelial cells.Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice Protein Inhibitor of Activated STAT3 Suppresses Oxidized LDL-induced Cell Responses during Atherosclerosis in Apolipoprotein E-deficient Mice.An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.Association of Systemic Arterial Properties With Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study.Potential proinflammatory effects of hydroxyapatite nanoparticles on endothelial cells in a monocyte-endothelial cell coculture model.Epstein-Barr virus-induced gene 3 (EBI3) can mediate IL-6 trans-signaling.Targeted myocardial gene expression in failing hearts by RNA sequencing.Cytokine amplification and macrophage effector functions in aortic inflammation and abdominal aortic aneurysm formation.Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo.Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer.Periodic vs constant high glucose in inducing pro-inflammatory cytokine expression in human coronary artery endothelial cells.The Potential of a Novel Class of EPAC-Selective Agonists to Combat Cardiovascular Inflammation.Molecular mechanisms of the effects of the ethanolic extract of Muntingia calabura Linn. fruit on lipopolysaccharide-induced pro-inflammatory mediators in macrophages.Increased activity of vascular adenosine deaminase in atherosclerosis and therapeutic potential of its inhibition.Activation of STAT3 stimulates AHSP expression in K562 cells.Cytosolic Hsp60 orchestrates the survival and inflammatory responses of vascular smooth muscle cells in injured aortic vessels.Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients.

P2860

Q26774389-DA022589-1294-4E49-8559-D4D404A30DEA Q28076558-BA9863CE-2D11-4A1D-ACB1-107A4E947B3E Q28384533-97F5DAF4-B85D-4A5A-8431-CE8D73F5FD6C Q33838927-DFC29A87-0C4E-48E9-9B94-79C662DF31F9 Q33900968-2E46E6AE-AA98-40D3-ADC1-992C1961D5DC Q34465923-AED3A411-F397-4B56-8FFB-B1C4E038C532 Q34483207-FCF631B7-A4FB-4A09-B837-5B1EF566C6C8 Q35200879-B98C0FA6-11EA-48DA-BB90-F0D7E6B0A3E7 Q35323328-2A24564F-CE6A-4DFF-9FC7-E3BE9ED349B6 Q35743848-FC791F0C-8B01-4850-A336-F146839B77E4 Q36085075-C129F035-EE1E-447D-BCE5-2BC9DE259EB4 Q36223307-D4F69907-37F2-4740-A76D-0A2255FC39C2 Q36767218-C2850F10-856E-4A5C-B0E0-F6AAB2C238AF Q36957831-952CD7BB-AEF6-4D3F-9FE6-AB5ACFDCF692 Q37111982-3D9C8682-BEFD-4AA1-A7F5-AC4A11A90302 Q37281580-7A0FC8E5-B254-48F1-8CD4-C56EE1E3C468 Q37414017-DA370686-61DC-474A-BCB6-69CE000B025E Q37452257-03732F14-0783-494C-8836-244AF1D986C3 Q37556260-BFBA735C-10A2-44BE-9970-9FA3867D2A8D Q37641673-A6ED7B5A-6185-4717-8C7F-E3B53EE0F7EB Q38712876-4619C91C-165E-426D-B96F-AAE722806FC3 Q39156232-42623945-C644-468F-A6CB-3B9169809486 Q41114435-5909BCD4-0A21-4671-BEA5-FEA7381155CB Q41855979-0EC19C8B-2F76-4D14-88A7-D4B62F33E04F Q43527544-920D74BF-ACDC-46FD-AE4D-C9B4E6B46C24 Q45292071-B8B2A595-76DF-448C-BE28-F6DD511FC1E8 Q48172039-0BEBCD65-9E52-4E8D-AF39-103AF3FCC3FA Q48200133-C6BBDBAC-09B2-4153-A5AA-FB326CD248F5 Q50174319-18DCF56B-3DEF-4EE5-9834-52F7A18842BB Q51517627-BCD31253-6168-452E-9B27-4418325A3FD4 Q53544015-53D32F6E-74FF-44B4-BC60-78B871C7DEDE Q53674344-D6DF5673-A245-49FC-ADF2-7DD05293CABF

P2860

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

http://www.wikidata.org/entity/Q37429079

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@en

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@nl

type

label

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@en

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@nl

prefLabel

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@en

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@nl

P1433

Q37429079-E7F338D2-73ED-4DBB-BA26-DB31018E503D

P1476

Q37429079-D01701D9-27E4-4F61-90E4-A883213AB45B

P2093

Q37429079-001E28F5-87F5-4F0F-BAFB-55050B684C12

Q37429079-12EACE1F-F362-410B-AB20-ECA483D4C72D

Q37429079-552ED21E-9559-4979-A6ED-B489E46CF97A

Q37429079-64FF9D8A-0F06-4CB5-B805-184239B21D10

Q37429079-AF20A2F2-70E1-49E3-A5B8-47DD1061BDBE

Q37429079-B851E923-76D9-4275-ADAC-B44CE313CE89

Q37429079-C6DABBFC-DAA4-46E7-8004-F6777179FE6F

P2860

Q37429079-021EFC09-421E-4C02-A4F0-A962CD593562

Q37429079-02B824DD-31A1-45B4-8F3E-CA60A3C1E5CA

Q37429079-02FF6E9C-4E69-4E7C-B010-1C575722F28F

Q37429079-052383C2-1758-4643-887B-89C3775731F7

Q37429079-05735264-3B28-4000-A1F5-6B32D3C0E87C

Q37429079-0607FE6D-A5CE-47D7-95C4-AB806905D1B4

Q37429079-08149710-553E-4142-B4CB-C9B50F48ADA0

Q37429079-0A320874-834C-4E91-BD96-8B50F4C06167

Q37429079-0B569F5D-6CBF-44CD-AE71-AE9C470F15CD

Q37429079-0C17D8D9-E631-47D3-A1CF-A1912971F852

P304

Q37429079-B1F4D031-30E2-4C9C-BE6C-9EC1093937D0

P31

Q37429079-595A41FA-9092-46E5-8BC4-1EA4FF3DDA1D

P356

Q37429079-CEB1DE8D-7081-4ACE-97E6-44D16AC33657

P433

Q37429079-A4409622-1495-4BD7-B350-ACA116AE2071

P478

Q37429079-3ACE89D4-6F91-40B4-A305-CD2B37359BD7

P577

Q37429079-05A080CB-0E16-4A7C-8B0D-F10063D25979

P5875

Q37429079-DB24BA75-712D-4907-AB71-1F92B1900376

P698

Q37429079-18DB635D-E80E-4C96-B97F-92A6DF60B57B

P921

Q37429079-841F50F7-4004-43D9-993B-55046837A9F2

P932

Q37429079-A26C12D7-5D1F-4D4B-B323-816E6DF353F4

P356

157340308785160570

P1433

Current cardiology reviews

P1476

Roles of IL-6-gp130 Signaling in Vascular Inflammation.

@en

P2093

Adrian Recinos Iii

http://www.w3.org/2001/XMLSchema#string

Allan R Brasier

http://www.w3.org/2001/XMLSchema#string

Brian C Tieu

http://www.w3.org/2001/XMLSchema#string

Ronald G Tilton

http://www.w3.org/2001/XMLSchema#string

Ruwen Cui

http://www.w3.org/2001/XMLSchema#string

Sutapa Ray

http://www.w3.org/2001/XMLSchema#string

Tieying Hou

http://www.w3.org/2001/XMLSchema#string

P2860

Both Stat3-activation and Stat3-independent BCL2 downregulation are important for interleukin-6-induced apoptosis of 1A9-M cells

The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression

Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex

Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes

Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabolism

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

CARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells

Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress

Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance

SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130

P304

179-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/157340308785160570

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40029497

http://www.w3.org/2001/XMLSchema#string

P698

19936194

http://www.w3.org/2001/XMLSchema#string

P921

P932

2780819

http://www.w3.org/2001/XMLSchema#string